Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro's golden dose — the 2.5 mg starter pen — does not use insulin needles. Each KwikPen comes with its own integrated delivery mechanism and is designed to work with the specific pen needles supplied or recommended for tirzepatide, not with the separate syringes or short-hub needles used in insulin therapy. If you've arrived here wondering whether you can substitute an insulin needle, the short answer is: don't. Here's why that matters, and what you should actually be using.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
They look similar. Both are small, both are used subcutaneously, and both get talked about in the same breath when people are new to injectable treatments. So it's an understandable assumption. But insulin needles (specifically the BD-style short-hub needles fitted to insulin syringes) are designed for a completely different delivery system. Mounjaro is administered via a KwikPen, a dial-and-inject device that attaches a standard external pen needle by a screw or click mechanism at the pen's tip. An insulin syringe needle cannot attach to this interface.
The confusion is compounded by the phrase "insulin needle" being used colloquially to mean any fine subcutaneous needle. A question our prescribers hear most weeks is some version of: "Can I just use the needles from my diabetic relative's kit?" The answer depends entirely on what those needles are. A compatible pen needle from a universal-fit pack? Possibly, if gauge and length suit you. An insulin syringe with a fixed needle? No.
The Mounjaro treatment overview covers the pen format in fuller detail, but the core point here is mechanical: the right needle attaches to the pen tip and delivers a metered dose. The wrong equipment either won't fit or will deliver an unpredictable volume. Neither outcome is acceptable when precision matters.
Each Mounjaro KwikPen is a 3 ml cartridge-based device. You attach a compatible pen needle before each injection and remove it immediately afterwards. The pen needle must fit the standard thread or click-fit at the pen's tip, most 4 mm, 5 mm, and 8 mm universal pen needles from reputable manufacturers are compatible, though Eli Lilly's guidance in the Patient Information Leaflet (available via the Mounjaro SmPC on the eMC) specifies the needle types it has been tested with. That leaflet is the authoritative reference; nothing on this page supersedes it.
Gauge matters too. Most people use 31G or 32G needles, which are fine enough to minimise discomfort while delivering the dose reliably. Thicker gauges (lower numbers) push the medication faster and can increase site discomfort. Shorter needles (4 mm is common) reach the subcutaneous layer adequately for most adults regardless of body composition. If you're unsure which length suits you, that's a conversation for your prescriber.
For practical purchasing, the needles for the Mounjaro golden dose page goes into compatible options in more detail. And if you're specifically on the 2.5 mg pen, the guidance on what needles to use with the Mounjaro golden dose addresses the practical choices available in the UK.
The 2.5 mg golden dose is the adjustment period. Its job is to let your body acclimatise to tirzepatide before any dose escalation, not to produce weight-loss results in itself. That's a clinically important distinction, and it means this is the point in treatment where habits are formed: injection technique, rotation of sites, timing, and needle disposal. Getting these right at 2.5 mg makes every subsequent dose easier.
Injection sites for Mounjaro are the abdomen, thigh, or upper arm. Rotate the site each week; using the same spot repeatedly can cause lipohyotrophy, a hardening of the tissue that impairs absorption. A fresh pen needle for every injection is non-negotiable: a used needle is blunted, carries contamination risk, and can cause inaccurate dosing. Used needles belong in a sharps container, not a household bin. The NHS page on tirzepatide includes a summary of injection guidance alongside the side-effect profile.
If you're moving from the 2.5 mg starter to higher doses, the Mounjaro 5 mg page covers what changes at that stage. The needle setup itself doesn't change (same pen, same needle type) but knowing that in advance removes one source of uncertainty. And if cost is a consideration as your treatment progresses, the Mounjaro pricing page lays out what private treatment typically involves at each dose stage.
This question surfaces occasionally, and it's worth addressing plainly. Some people ask whether tirzepatide can be drawn from the KwikPen cartridge into a conventional insulin syringe, partly from curiosity, partly because syringe dosing feels more familiar to those with a diabetes background. The answer is no, and the reasons are practical, clinical, and legal.
First, the KwikPen is not designed to be decanted. The cartridge is sealed and the mechanism is calibrated for pen-needle delivery. Drawing up introduces contamination risk and almost certainly produces an inaccurate dose. Second, the golden dose needle guidance specifically addresses why the pen's integrated dosing system should not be bypassed. Third, doing so voids any guidance your prescriber has given, because you're no longer using the medicine as licensed.
For anyone researching the 2.5 mg dose more broadly, the page on 2.5 mg Mounjaro in an insulin syringe covers this question in full, including what the risks are and why it's not a route any legitimate prescriber would support. On the question of needle sizing specifically, what size needle to use for the Mounjaro golden dose offers a practical breakdown of gauge and length options.
Mounjaro is a prescription-only medicine. Every aspect of how it's used, stored, and administered should sit within your prescriber's guidance and the instructions in your Patient Information Leaflet. If you have questions about your specific setup, our clinical team at our prescriber profile page explains who reviews your treatment and what ongoing support looks like. To explore whether tirzepatide is right for you, check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.